282 related articles for article (PubMed ID: 26863249)
1. The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.
DeDeugd C; Miyake M; Palacios DA; Rosser CJ
J Racial Ethn Health Disparities; 2015 Mar; 2(1):124-31. PubMed ID: 26863249
[TBL] [Abstract][Full Text] [Related]
2. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.
Underwood W; Dunn RL; Williams C; Lee CT
J Am Coll Surg; 2006 Feb; 202(2):284-90. PubMed ID: 16427554
[TBL] [Abstract][Full Text] [Related]
3. Survival disparities among African American women with invasive bladder cancer in Florida.
Brookfield KF; Cheung MC; Gomez C; Yang R; Nieder AM; Lee DJ; Koniaris LG
Cancer; 2009 Sep; 115(18):4196-209. PubMed ID: 19569251
[TBL] [Abstract][Full Text] [Related]
4. Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
Washington SL; Gregorich SE; Meng MV; Suskind AM; Porten SP
Cancer Med; 2020 Nov; 9(22):8310-8317. PubMed ID: 32869516
[TBL] [Abstract][Full Text] [Related]
5. Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.
Kaye DR; Canner JK; Kates M; Schoenberg MP; Bivalacqua TJ
Bladder Cancer; 2016 Apr; 2(2):225-234. PubMed ID: 27376141
[No Abstract] [Full Text] [Related]
6. Comparative outcomes of bladder cancer.
Cárdenas-Turanzas M; Cooksley C; Pettaway CA; Sabichi A; Grossman HB; Elting L
Obstet Gynecol; 2006 Jul; 108(1):169-75. PubMed ID: 16816072
[TBL] [Abstract][Full Text] [Related]
7. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
8. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.
Verma PS; Howard RS; Weiss BM
Am J Hematol; 2008 May; 83(5):355-8. PubMed ID: 18186525
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
Dignam JJ
J Natl Cancer Inst Monogr; 2001; (30):36-43. PubMed ID: 11773290
[TBL] [Abstract][Full Text] [Related]
10. Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
Sartor O; Armstrong AJ; Ahaghotu C; McLeod DG; Cooperberg MR; Penson DF; Kantoff PW; Vogelzang NJ; Hussain A; Pieczonka CM; Shore ND; Quinn DI; Small EJ; Heath EI; Tutrone RF; Schellhammer PF; Harmon M; Chang NN; Sheikh NA; Brown B; Freedland SJ; Higano CS
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):517-526. PubMed ID: 32111923
[TBL] [Abstract][Full Text] [Related]
11. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
Wenzel M; Deuker M; Stolzenbach F; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Kluth LA; Chun FKH; Karakiewicz PI
Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Cole AP; Fletcher SA; Berg S; Nabi J; Mahal BA; Sonpavde GP; Nguyen PL; Lipsitz SR; Sun M; Choueiri TK; Preston MA; Kibel AS; Trinh QD
Cancer; 2019 Apr; 125(8):1319-1329. PubMed ID: 30633323
[TBL] [Abstract][Full Text] [Related]
14. Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care.
Pamboukian SV; Costanzo MR; Meyer P; Bartlett L; McLeod M; Heroux A
J Card Fail; 2003 Apr; 9(2):80-6. PubMed ID: 12751127
[TBL] [Abstract][Full Text] [Related]
15. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting outcomes after radical cystectomy in African Americans.
Konety BR; Allareddy V; Carroll PR
Cancer; 2007 Feb; 109(3):542-8. PubMed ID: 17200961
[TBL] [Abstract][Full Text] [Related]
17. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
18. Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.
Frei CR; Mortensen EM; Copeland LA; Attridge RT; Pugh MJ; Restrepo MI; Anzueto A; Nakashima B; Fine MJ
BMC Health Serv Res; 2010 May; 10():143. PubMed ID: 20507628
[TBL] [Abstract][Full Text] [Related]
19. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
